11 May 2016The human rights ‘win’ at the UNGASS on drugs that no one is talking about, and how we can use itWhilst disappointing, the Outcome Document includes new language on human rights that could mean progress after the UNGASS 2016
11 May 2016Cannabis and the conventions: UNGASS and beyondIn this video, Uruguayan and Jamaican government officials join civil society organisations in explaining recent developments in drug policies at the UNGASS 2016.
10 May 2016Region’s harsh drug policies slammed by expertsSoutheast Asian countries accused of sticking with ineffective and harmful anti-drug policies at UNGASS 2016.
10 May 2016Why “harm reduction” means something different in MexicoSubstance analysis opens a window of opportunity to talk about safer ways to use drugs.
9 May 2016Colombia’s contradictory return to coca fumigationThe Colombian government restarted use of the harmful and ineffective herbicide glyphosate.
9 May 2016Women and the war on drugsWomen victims of drug policies joined a caravan for peace to underscore the need to approach drug policy reform as a women's issue.
9 May 2016California recreational marijuana initiative will be on the November ballotAn initiative to legalize recreational marijuana in California has collected more than 600,000 signatures.
6 May 2016Is there an alternative to repressive drug policies?A regional meeting in Kiev marks the beginning of a discussion on drug policy reform in EECA countries
6 May 2016Between rhetoric and reform: criminal justice reform in the United StatesCurrently ongoing innovative drug policy reform in the US seeks to decrease incarcerations.
6 May 2016Germany is about to legalise medical marijuanaGerman Health Minister announced the legalisation of medical cannabis for early 2017.
6 May 2016Consensus crumbling: report from the UN general assembly special session on drugsA group of countries reaffirm their desire to break away from the prohibitionist consensus at the end of the 2016 UNGASS.
6 May 2016UNGASS 2016: from opportunity to opportunismHardline countries have pushed for keeping the status quo, preventing any effective changes in the global drug problem.